Asklepios Places New EUR 600.0 Million Social Schuldschein Loan

2025-10-29 02:08:51

(MENAFN- EQS Group)

EQS-Media / 29.10.2025 / 10:00 CET/CEST

Asklepios places new EUR 600.0 million
Social Schuldschein loan

Keen interest from international investors
Issuance proceeds to be used for refinancing

Hamburg , 29 October 2025. Asklepios Kliniken GmbH & Co. KGaA has successfully placed a Social Schuldschein loan in the amount of EUR 600.0 million. The issue is being used for early re-financing of Schuldschein maturities in 2025, 2026 and 2027 and has seen strong demand by existing and new investors.
The new Social Schuldschein loan was placed with maturities of 3, 5, 7 and 10 years and is the second Social Schuldschein issued under the Asklepios Group's Social Finance Framework, which can be used to allocate funding to the area of social healthcare infrastructure.
The success of the transaction depended decisively on securing a high prolongation rate for existing investors and acquiring new investors from abroad. In an overall liquid Schuldschein market, this year's transaction met with a high level of interest.
“The new Social Schuldschein loan allows us to further develop the strategy of our finance portfolio and to actively manage the financing maturities.”, noted Hafid Rifi, Chief Financial Officer of the Asklepios Group.“What was especially key for the success of this year's financing transaction was the keen interest shown by new international investors along with a resilient Schuldschein market.”, Rifi added.“With international investors making up a share of 52%, we have succeeded in further diversifying our investor base.”
“The early refinancing of Schuldschein maturities in 2026 and 2027 was achieved through bilateral agreements with existing investors.”, continued Benedikt Brörmann, Head of Corporate Finance & Treasury at Asklepios.“Key to this success is a longstanding and trusted business relationship with our investors”, Brörmann explained.
The placement of the Social Schuldschein loan was supported by Commerzbank, DZ Bank and Landesbank Baden-Württemberg as arrangers. Linklaters LLP acted as Asklepios' legal advisor.
About Asklepios
Asklepios Kliniken is one of the leading operators of private hospitals and healthcare facilities in Germany. The hospital group has an established track record for delivering high-quality medical care to its patients with a clear commitment to medical quality, innovation and social responsibility. This is what has underpinned Asklepios' dynamic development ever since its founding more than 35 years ago. Currently, the Group has some 160 healthcare facilities throughout Germany. These include acute hospitals of all care levels, university hospitals, specialised clinics, psychiatric and forensic facilities, rehabilitation hospitals, nursing homes and medical care centres. During financial year 2024, over 3.6 million patients were treated at Asklepios' healthcare facilities.
Contact for queries:
Creditor Relations contact:
Stefan Sinzel
Manager Corporate Finance
Asklepios Kliniken GmbH & Co. KGaA
Debusweg 3 – 61462 Königstein-Falkenstein
Tel.: +49 6174 9011-96
E-mail: ...
Investor Relations contact:
Sarah Ludwig
Head of Investor Relations
Asklepios Kliniken GmbH & Co. KGaA
Debusweg 3 – 61462 Königstein-Falkenstein
Tel.: +49 6174 9011-72
E-mail: ...
Media contact:
Rune Hoffmann
Head of Corporate Communications & Marketing
Asklepios Kliniken GmbH & Co. KGaA
Rübenkamp 226 – 22307 Hamburg
Tel.: +49 40 1818-82 6630
Fax: +49 40 1818-82 6639
E-mail: ...
Visit Asklepios on the Internet, Facebook or YouTube:

/konzern/gesundheitsmagazin

Sign up for the Asklepios Newsletter:
blog:“ href="">Wir sind Pfleg”

End of Media Release
Issuer: Asklepios Kliniken
Key word(s): Finance

29.10.2025 CET/CEST Dissemination of a Press Release, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News

2220064 29.10.2025 CET/CEST

MENAFN29102025004691010666ID1110266148

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.